TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
PGEN

Precigen Inc

Healthcare · Biotechnology

7.70$ +3.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Precigen Inc (PGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 9.7 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PGEN
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
8.0 14 24 72 174 191 231 161 32 32 14 27 6.2 3.9 9.7
– 64 48 19 64 62 63 63 5.4 45 54 6.3 6.1 4.3 6.1
8.0 -50 -24 53 110 129 168 97 27 -13 -39 21 0.1 -0.3 3.6
70 64 48 59 147 112 143 405 39 39 48 47 49 53 40
– 25 34 64 109 142 146 138 101 92 74 48 40 41 70
90 89 82 123 257 254 289 542 113 74 53 96 100 135 110
-82 -75 -58 -70 -147 -125 -138 -506 -86 -86 -92 -76 -100 -135 -107
0.2 0.1 0.1 0.7 1.2 0.9 0.6 8.5 18 18 19 6.8 0.5 0.0 3.9
-85 -82 -41 -86 -87 -194 -130 -536 -105 -105 -111 -80 -96 -128 -251
0.2 -0.3 -9.8 -0.1 1.0 -3.9 -2.9 -22 -0.1 -0.1 -0.2 -0.2 -0.5 -1.8 0.0
-85 -82 -39 -82 -84 -187 -117 -509 -171 -171 -92 28 -96 -126 -251
-81 -74 -34 -75 -68 -169 -98 -349 -69 -68 -78 -62 -89 -123 -244

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?